David Silverstone, MD

Dr. Silverstone received his undergraduate degree from Columbia College and his M.D. from New York Medical College. He completed his ophthalmology residency, a glaucoma research fellowship, and a chief residency in ophthalmology at Yale. He did a fellowship in Intraocular Lens Implantation at New York Medical College. Dr. Silverstone has been the Assistant Chief of Ophthalmology at Yale-New Haven Hospital since 1988. He has also served as the Chief of Ophthalmology at the West Haven, Connecticut VA Medical Center.

Dr. Silverstone was part of the Yale team, under Dr. Marvin Sears, that developed Timolol, the first modern medication for the treatment of glaucoma. His pharmaceutical research interests include the medical treatment of glaucoma and the role of anti-inflammatory medications in post-surgical patient management. Dr. Silverstone has played a leading role in the development of Medical Information Technology. His research interests have included the development of electronic medical record technology, decision support software strategies and assuring data integrity in electronic health records. He has also worked on the development of visual field testing devices and co-authored a book on visual field testing with Yale neuroscientist Dr. Joy Hirsch.

Dr. Silverstone has served as both the Director of Continuing Medical Education and the Chair of the Health Information Technology Subcommittee of the American Society of Cataract and Refractive Surgery. He has served on the Governing Board of the American Society of Ophthalmic Administrators and was a founding member of the National Board for Certified Ophthalmic Executives. He is a fellow of the American Academy of Ophthalmology, which has awarded him its Senior Honor Award, has served on its Medical Information Technology Committee, and is currently a member of the Academy’s IRIS Disease Registry Operations Task Force.